Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia-Reference-Cited by-同舟云学术

Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia

Published:2002-09 Issue:1 Volume:71 Page:1-6
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Ruggeri Marco,Gisslinger Heinz,Tosetto Alberto,Rintelen Claudia,Mannhalter Christine,Pabinger Ingrid,Heis Navide,Castaman Giancarlo,Missiaglia Edoardo,Lechner Klaus,Rodeghiero Francesco

Publisher

Wiley

Subject

Hematology

Reference33 articles.

1. Bleeding and thrombosis in the myeloproliferative disorders

2. Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia.

3. Hydroxyurea for Patients with Essential Thrombocythemia and a High Risk of Thrombosis

4. Low protein s in essential thrombocythemia with thrombosis

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Splenic infarction secondary to polycythemia Vera: Case report and literature review;Radiology Case Reports;2023-10

2. Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology;Diagnostics;2023-01-03

3. Recent Advances in the Use of Molecular Analyses to Inform the Diagnosis and Prognosis of Patients with Polycythaemia Vera;International Journal of Molecular Sciences;2021-05-10

4. Molecular genetics of thrombotic myeloproliferative neoplasms: Implications in precision oncology;Genes & Diseases;2021-01

5. Management and Outcome of Venous Thrombosis in Patients with Myeloproliferative Neoplasms: Data from the Israeli MPN Working Group;Acta Haematologica;2020-12-14